The relevance of the bleeding severity in the treatment of acquired haemophilia - an update of a single-centre experience with 67 patients

Haemophilia

Volumn 16, Issue 102, 2010, Pages 95-101

  Zeitler, H ^a   Ulrich Merzenich, G ^a   Goldmann, G ^a   Vidovic, N ^a   Brackmann, H H ^a   Oldenburg, J ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Acquired haemophilia; Activated partial thromboplastin time; FVIII; Immune tolerance induction; Immunoadsorption; Immunomodulation; MBMP protocol

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISOLONE;

ACQUIRED HEMOPHILIA; ADULT; ANTIBODY TITER; APHERESIS; ARTICLE; BLEEDING; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; HEMOPHILIA; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REMISSION; SUBSTITUTION THERAPY;

AGED; BLOOD COAGULATION FACTOR INHIBITORS; CYCLOPHOSPHAMIDE; FACTOR VIIA; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; HEMOPHILIA A; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS;

EID: 77953226730     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01922.x     Document Type: Article

References (21)

1. Franchini M. Acquired factor VIII inhibitors in oncohematology: a systematic review: Crit Rev Oncol Hematol. 2008, Epub ahead of print
2. Collins PW. Treatment of acquired hemophilia. J Thromb Haemost 2007, 5:893-900.
3. Ng HJ, Tan DC, Lee LH. Treatment and outcome of acquired haemophilia A with a standard conventional regime in a cohort without associated conditions. Haemophilia 2006, 12:423-8.
4. Garvey B. Rituximab in the treatment of autoimmune haematological disorders. Br J Haemtol 2008, 141:149-69.
5. Millet A, Decaux O, Bareau B. Efficiency of rituximab in acquired hemophilia. Report of two cases and review of literature. Rev Med Intern 2007, 12:862-5.
6. Stachnik JM. Rituximab in the treatment of acquired hemophilia. Ann Pharmacother 2006, 40:1151-7.
7. Lambotte O, Dautremer J, Guillet B. Acquired hemophilia in older people: a poor prognosis despite intensive care. J Am Geriatr Soc 2007, 55:1682-5.
8. Franchini M, Tagliaferri A, Mannucci PM. The management of hemophilia in elderly patients. Clin Interv Aging 2007, 2:361-8.
9. Delgado J, Yuste V, Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. Br J Haematol 2003, 121:21-35.
10. Collins PW, Hirsch S, Baglin TP. UK Haemophilia Centre Doctors Organisation; acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors Organisation. Blood 2007, 109:1870-7.
11. Zeitler H, Ulrich-Merzenich G, Hess L. Treatment of acquired hemophilia by the Bonn-Malmö protocol: documentation of an in vivo immunomodulating concept. Blood 2005, 105:2287-93.
12. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitor - twenty years " Bonn protocol" Vox Sang 1996, 70:30-5.
13. Giles AR, Verbruggen B, Roivard GE, Teitel J, Walker I. A detailed comparison of the performance of the standard versus Nijmegen modification of the Bethesda assay in detecting factor VIII: inhibitors in the haemophilia a population of Canada. Thromb Haemost 1998, 79:872-5.
14. Zeitler H, Ulrich-Merzenich G, Walger P. Treatment of factor VIII inhibitors with selective IgG immunoadsorption - a single centre experience in 50 patients with acquired hemophilia. Transfus Med Hemother 2006, 33:160-4.
15. Lleo A, Battezzati PM, Semi C. Is autoimmunity a matter of sex? Autoimmun Rev. 2008, Epub ahead of print
16. Sumner MJ, Geldziler BD, Pedersen M, Seremetis S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 2007, 13:451-61.
17. Diringer MN, Skolnick BE, Mayer SA. Risk of thromboembolic events in controlled trials of rFVIa in spontaneous intracerebral hemorrhage. Stroke 2008, 3:850-6.
18. Isbister J, Philipps L, Dunkley S. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand. Haemost Regist Intern Med J 2008, 3:153-65.
19. Sumner MJ, Geldziler BD, Pedersen M. Treatment of acquired haemophilia with recombinant activated FVII. A critical appraisal. Haemophilia 2007, 13:451-61.
20. Hausl C, Ahmed RU, Sasgary M, Doering CB, Lollar P, Richter G. High dose factor VIII inhibits factor VIII specific memory cells in hemophilia A with factor VIII inhibitors. Blood 2005, 10:3415-22.
21. Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001, 5:389-404.